Biblio Discovery — Demo Discovery Service

27 results for "Andruska, Neal"

Showing 1–20 · 0.35 seconds · RSS

  1. Journal Article Full text

    Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferation()

    Yu, Liqun; Andruska, Neal; Zheng, Xiaobin et al.

    Mol Cell Endocrinol · 2015 · English · PubMed Central

    The onco-protein epidermal growth factor (EGF) initiates a cascade that includes activation of the ERK and AKT signaling pathways and alters gene expression. We describe a new action of EGF–EGF receptor (EGFR), rapid anticipatory activation of the endoplasmic reticulum stress sensor, the unfolded…

  2. Journal Article Full text

    Severe pneumonitis refractory to steroids following anti-PD-1 immunotherapy

    Andruska, Neal; Mahapatra, Lily; Hebbard, Carleigh et al.

    BMJ Case Rep · 2018 · English · PubMed Central

    Anti-programmed death 1 (PD-1) immune checkpoint inhibitors enhance the antitumour activity of the immune system and have produced durable tumour responses in several solid tumours including non-small cell lung cancer (NSCLC). However, PD-1 inhibitors can lead to immune-related adverse events…

  3. Journal Article Full text

    High-Throughput Fluorescence Anisotropy Screen for Inhibitors of the Oncogenic mRNA-binding Protein, IMP-1

    Mahapatra, Lily; Mao, Chengjian; Andruska, Neal et al.

    J Biomol Screen · 2013 · English · PubMed Central

    Cancer cell proliferation is regulated by oncogenes, such as c-Myc. An alternative approach to directly targeting individual oncogenes is to target IMP-1, an oncofetal protein that binds to and stabilizes mRNAs, leading to elevated expression of c-Myc and other oncogenes. Expression of IMP-1 is…

  4. Journal Article Full text

    Evaluation of a Luciferase-based Reporter Assay as a Screen for Inhibitors of Estrogen-ERα-induced Proliferation of Breast Cancer Cells

    Andruska, Neal; Mao, Chengjian; Cherian, Mathew et al.

    J Biomol Screen · 2012 · English · PubMed Central

    Estrogens, acting through estrogen receptor α (ERα), stimulate breast cancer proliferation, making ERα an attractive drug target. Since 384-well format screens for inhibitors of proliferation can be challenging for some cells, inhibition of luciferase-based reporters is often used as a surrogate…

  5. Journal Article Full text

    Anticipatory UPR Activation: A Protective Pathway and Target in Cancer

    Shapiro, David J.; Livezey, Mara; Yu, Liqun et al.

    Trends Endocrinol Metab · 2016 · English · PubMed Central

    The endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR), plays a key role in regulating intracellular protein homeostasis. The extensively studied reactive mode of UPR activation is characterized by unfolded protein, or other EnR stress, triggering UPR activation. Here we…

  6. Journal Article Full text

    A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation

    Mahapatra, Lily; Andruska, Neal; Mao, Chengjian et al.

    Transl Oncol · 2017 · English · PubMed Central

    The oncofetal mRNA-binding protein, IMP1 or insulin-like growth factor-2 mRNA-binding protein 2 (IGF2BP1), binds to and stabilizes c-Myc, β-TrCP1, and other oncogenic mRNAs, leading to increased expression of the proteins encoded by its target mRNAs. IMP1 is frequently overexpressed in cancer and…

  7. Journal Article Full text

    Anticipatory Estrogen Activation of the Unfolded Protein Response is Linked to Cell Proliferation and Poor Survival in Estrogen Receptor α Positive Breast Cancer

    Andruska, Neal; Zheng, Xiaobin; Yang, Xujuan et al.

    Oncogene · 2014 · English · PubMed Central

    In response to cell stress, cancer cells often activate the endoplasmic reticulum (EnR) stress sensor, the unfolded protein response (UPR). Little was known about the potential role in cancer of a different mode of UPR activation; anticipatory activation of the UPR prior to accumulation of unfolded…

  8. Journal Article Full text

    The Novel Use of a Commercially Available Video-Conference Platform to Facilitate Multidisciplinary Target Volume Review and Delineation for Skull-Base Radiation Therapy During the Coronavirus Disease 2019 Pandemic

    Roy, Amit; Andruska, Neal; Orlowski, Hilary L.P. et al.

    Adv Radiat Oncol · 2020 · English · PubMed Central

    Multidisciplinary involvement in radiation therapy (RT) treatment planning is currently underused. A radiation oncologist sought input for generating target contours from a neuro-radiologist (NR) and otolaryngologist (OL) for 3 patients requiring skull-base RT during the coronavirus disease 2019…

  9. Journal Article Full text

    Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold

    Stowe, Hayley B; Andruska, Neal D; Reynoso, Francisco et al.

    Breast Cancer (Dove Med Press) · 2022 · English · PubMed Central

    Adjuvant radiation therapy is a critical component of breast cancer management. However, when breast cancer patients receive incidental radiation to the heart, there is an increased risk of cardiac disease and mortality. This is most common for patients with left-sided breast cancers and those…

  10. Journal Article Full text

    A photostable monomeric superfolder GFP

    Valbuena, Fernando M.; Fizgerald, Ivy; Strack, Rita L. et al.

    Traffic · 2020 · English · PubMed Central

    The green fluorescent protein GFP from Aequorea victoria has been engineered extensively in the past to generate variants suitable for protein tagging. Early efforts produced the enhanced variant EGFP and its monomeric derivative mEGFP, which have useful photophysical properties, as well as…

  11. Journal Article Full text

    Interplay Between Steroid Hormone Activation of the Unfolded Protein Response and Nuclear Receptor Action

    Zheng, Xiaobin; Andruska, Neal; Yu, Liqun et al.

    Steroids · 2016 · English · PubMed Central

    To identify new pathways of estrogen action and novel estrogen receptor α (ERα) biomodulators, we performed high throughput screening and used follow on assays and bioinformatics to identify small molecule ERα inhibitors with a novel mode of action. These studies led to identification of rapid…

  12. Journal Article Full text

    Estrogen receptor α inhibitor activates the unfolded protein response, blocks protein synthesis, and induces tumor regression

    Andruska, Neal D.; Zheng, Xiaobin; Yang, Xujuan et al.

    Proc Natl Acad Sci U S A · 2015 · English · PubMed Central

    Recurrent estrogen receptor α (ERα)-positive breast and ovarian cancers are often therapy resistant. Using screening and functional validation, we identified BHPI, a potent noncompetitive small molecule ERα biomodulator that selectively blocks proliferation of drug-resistant ERα-positive breast and…

  13. Journal Article Full text

    Protein Kinase C Alpha is Upregulated by IMP1 in Melanoma and is Linked to Poor Survival

    Mahapatra, Lily; Andruska, Neal; Mao, Chengjian et al.

    Melanoma Res · 2019 · English · PubMed Central

    The oncofetal mRNA binding protein, IMP1 or insulin-like growth factor-2 mRNA-binding protein 1 [IGF2BP1], promotes the overexpression of several oncogenic proteins by binding to and stabilizing their mRNAs. IMP1 is frequently overexpressed in melanoma and is associated with a poor prognosis, but…

  14. Journal Article Full text

    Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response

    Zheng, Xiaobin; Andruska, Neal; Lambrecht, Michael J. et al.

    Oncotarget · 2016 · English · PubMed Central

    Ovarian cancers often recur and tumors acquire resistance to chemotherapy due to overexpression of the ATP-dependent efflux pump, multidrug resistance protein 1 (MDR1/P-glycoprotein/ABCB1). Nontoxic small molecule inhibitors targeting MDR1 have remained largely elusive. Instead, in a novel…

  15. Journal Article Full text

    The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy

    Waters, Michael R; Andruska, Neal; Fischer-Valuck, Benjamin W et al.

    Cureus · 2023 · English · PubMed Central

    Introduction Stereotactic body radiation therapy (SBRT) for prostate adenocarcinoma (PCa) has demonstrated excellent biochemical recurrence-free survival, with studies showing improved BRFS with higher-dose SBRT. However, current studies have been underpowered to evaluate the relationship of SBRT…

  16. Journal Article Full text

    Outcomes of Unfavorable Intermediate-Risk Prostate Cancer Patients Treated with External Beam Radiotherapy vs. Brachytherapy Alone

    Andruska, Neal; Fischer-Valuck, Benjamin W.; Carmona, Ruben et al.

    J Natl Compr Canc Netw · 2022 · English · PubMed Central

    BACKGROUND: The NCCN currently recommends several definitive radiotherapy options for men with unfavorable intermediate-risk (UIR) prostate cancer including external beam radiotherapy (EBRT) + androgen deprivation therapy (ADT) or EBRT + brachytherapy boost ± ADT. However, brachytherapy alone (BT)…

  17. Journal Article Full text

    Is the addition of brachytherapy and/or androgen deprivation therapy associated with improved overall survival in unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy?

    Andruska, Neal; Fischer-Valuck, Benjamin W.; Carmona, Ruben et al.

    Brachytherapy · 2022 · English · PubMed Central

    BACKGROUND: Current recommendations regarding radiotherapy treatment for unfavorable intermediate-risk prostate cancer (UIR-PCa) include external beam radiotherapy (EBRT) ± brachytherapy boost (BT) ± androgen deprivation therapy (ADT). The ideal radiotherapy treatment approach for UIR-PCa has not…

  18. Journal Article Full text

    Assessing the role of external beam radiation therapy in combination with brachytherapy vs. brachytherapy alone for unfavorable intermediate-risk prostate cancer

    Andruska, Neal; Michalski, Jeff M.; Carmona, Ruben et al.

    Brachytherapy · 2022 · English · PubMed Central

    BACKGROUND: Definitive treatment options for unfavorable intermediate-risk prostate cancer (UIR-PCa) include external beam radiotherapy (EBRT) ± brachytherapy boost ± androgen deprivation therapy (ADT). The role of brachytherapy ± ADT in the absence of EBRT is not well defined. We hypothesized that…

  19. Journal Article Full text

    Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer

    Andruska, Neal; Fischer-Valuck, Benjamin W.; Agabalogun, Temitope et al.

    Clin Genitourin Cancer · 2021 · English · PubMed Central

    BACKGROUND: Prostate stereotactic body radiotherapy (SBRT), which delivers high-dose precision treatment in ≤5 fractions, is a shorter, more convenient, and less expensive alternative to conventionally fractionated radiotherapy (CRFT; ~44 fractions) or moderately hypofractionated radiotherapy…